Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Spanjaart AM"'
Autor:
Amin AS, Boink GJ, Atrafi F, Spanjaart AM, Asghari-Roodsari A, Molenaar RJ, Ruijter JM, Wilde AA, Tan HL
Publikováno v:
EP: Europace; Jul2011, Vol. 13 Issue 7, p968-975, 8p
Autor:
Adrian Bloor, Nicolaus Kröger, Gloria Tridello, Alvaro Urbano-Ispizua, Roberta Di Blasi, Joaquin Martinez-Lopez, František Folber, Josep-Maria Ribera, Elisabetta Metafuni, Robin Sanderson, Marie José Kersten, Catherine Thieblemont, Friso Calkoen, Livia Giannoni, Pim G.N.J. Mutsaers, Matthew Collin, Arnon Nagler, Emma Nicholson, Emmanuel Bachy, Fiona L Dignan, Valentín Ortiz-Maldonado, Dolores Caballero, Johan Maertens, Per Ljungman, Pere Barba, Carlos Pinho Vaz, Francis Ayuk, Mi Kwon, Fabio Ciceri, Stephan Mielke, Pierre Sesques, Nina Knelange, Anne M. Spanjaart, Rafael de la Cámara
Publikováno v:
Scientia
Leukemia, 35(12), 3585-3588. Nature Publishing Group
Leukemia
Leukemia, 35(12), 3585-3588. Nature Publishing Group
Leukemia
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Càncer hematològic; Malalties infeccioses Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Cáncer hematológico; Enfermedades infecciosas Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Haematological cancer;
Autor:
Spanjaart AM; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands., Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center, Stockholm, Sweden., Tridello G; European Society for Blood and Marrow Transplantation (EBMT) Data Office, Department of Medical Statistics & Bioinformatics, Leiden, Netherlands., Schwartz J; European Society for Blood and Marrow Transplantation (EBMT) Leiden Study Unit, European Society for Blood and Marrow Transplantation (EBMT) Data Office, Leiden, Netherlands., Martinez-Cibrián N; Department of Hematology, Hospital Clínic, Barcelona, Spain., Barba P; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain., Kwon M; Department of Hematology, Hospital G. Universitario Gregorio Marañon, Institute of Health Research Gregorio Marañon, Madrid, Spain., Lopez-Corral L; Department of Hematology, Hospital Universitario de Salamanca and IBSAL, Salamanca, Spain., Martinez-Lopez J; Department of Hematology, Hospital Univ. 12 de Octubre, Complutense University, CNIO, Madrid, Spain., Ferra C; Clinical Hematology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Barcelona, Spain., Di Blasi R; Department of Hematology, Assistance Publique Hôpitaux de Paris-Hopital Saint-Louis, Paris, France., Ghesquieres H; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Mutsaers P; Department of Hematology, Erasmus MC Cancer Center, Rotterdam, the Netherlands., Calkoen F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., van Doesum J; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., van der Poel M; Department of Hematology, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands., Maertens J; Deptartment of Hematology, University Hospital Gasthuisberg, Leuven, Belgium., Gambella M; Department of Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Metafuni E; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Ciceri F; Hematology and BMT Unit IRCCS San Raffaele Scientific Institute, Milan, Italy., Saccardi R; Cell Therapy and Transfusion Medicine Unit Azienda Ospedaliero Universitaria Careggi, Firenze, Italy., Nicholson E; Department of Haematology, The Royal Marsden Hospital, London, United Kingdom., Tholouli E; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK., Matthew C; Adult HSCT unit, Northern Centre for Bone Marrow Transplantation, Newcastle Tyne, UK., Potter V; King's College Hospital NHS Foundation Trust, Department of Haematological Medicine, Denmark Hill, London, UK., Bloor A; Adult Leukaemia and Bone Marrow Transplant Unit, Christie NHS Foundation Trust Hospital, University of Manchester, Manchester, UK., Besley C; Department of Haematology, University Hospitals Bristol and Weston NHSFT, Bristol, UK., Roddie C; Department of Haematology, University College London Hospital, London, UK., Wilson K; Blood and Bone Marrow Transplantation Department, University Hospital of Cardiff, Cardiff, UK., Nagler A; Chaim Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel., Campos A; Celular Therapy Department, Instituto Portugués de Oncologia do Porto, Francisco Gentil, E.P.E, Porto, Portugal., Petersen SL; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Folber F; Department of internal Medicine, Hematology and Oncology, Masaryk University Hospital Brno, Brno, Czech Republic., Bader P; Department for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Finke J; Department of Hematology/Oncology/Stem Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany., Kroger N; Department of Stem cell Transplantation, University Hospital Eppendorf, Hamburg, Germany., Knelange N; European Society for Blood and Marrow Transplantation (EBMT) Leiden Study Unit, European Society for Blood and Marrow Transplantation (EBMT) Data Office, Leiden, Netherlands., de La Camara R; Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands., Mielke S; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Department of Laboratory Medicine, Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden. stephan.mielke@ki.se.; Cellular Therapy and immunobiology working party (CTIWP) of EBMT, . stephan.mielke@ki.se.
Publikováno v:
Leukemia [Leukemia] 2024 Sep; Vol. 38 (9), pp. 1985-1991. Date of Electronic Publication: 2024 Jul 23.
Autor:
Kuipers MT; Department of hematology, Amsterdam UMC, location university of Amsterdam, Amsterdam, The Netherlands and LYMMCARE., Spanjaart AM; Department of hematology, Amsterdam UMC, location university of Amsterdam, Amsterdam, The Netherlands and LYMMCARE., Bonifazi F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., diBlasi R; Université de Paris; Assistance Publique- Hôpitaux de Paris, AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris, France., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Thieblemont C; Université de Paris; Assistance Publique- Hôpitaux de Paris, AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris, France., Baudet M; Department of Cardiology, Hospital Saint-Louis, Paris, France., Biemond BJ; Department of hematology, Amsterdam UMC, location university of Amsterdam, Amsterdam, The Netherlands and LYMMCARE., Kok WEM; Department of Cardiology, Amsterdam UMC, location university of Amsterdam, Amsterdam, The Netherlands., Kersten MJ; Department of hematology, Amsterdam UMC, location university of Amsterdam, Amsterdam, The Netherlands and LYMMCARE.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 399-402. Date of Electronic Publication: 2023 Dec 09.
Autor:
de Boer JW; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Keijzer K; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Pennings ERA; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands., van Doesum JA; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Spanjaart AM; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., van Dorp S; Department of Hematology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands., van Dijk LV; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands., Niezink AGH; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., van Meerten T; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Nov 16; Vol. 15 (22). Date of Electronic Publication: 2023 Nov 16.
Autor:
de Boer JW; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Pennings ERA; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Kleinjan A; Department of Internal Medicine, Rivierenland Hospital, Tiel, The Netherlands., van Doesum JA; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Spanjaart AM; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kuipers MT; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Adam JA; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Koens L; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., van Dorp S; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Niezink AGH; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6710-6716.
Autor:
Lareau CA; Department of Pathology, Stanford University, Stanford, CA, USA. lareauc@mskcc.org.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. lareauc@mskcc.org.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. lareauc@mskcc.org.; Department of Genetics, Stanford University, Stanford, CA, USA. lareauc@mskcc.org.; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lareauc@mskcc.org., Yin Y; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Maurer K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sandor KD; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Daniel B; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Yagnik G; Allogene Therapeutics, South San Francisco, CA, USA., Peña J; Allogene Therapeutics, South San Francisco, CA, USA., Crawford JC; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA., Spanjaart AM; Department of Hematology, University of Amsterdam, Amsterdam, the Netherlands., Gutierrez JC; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Haradhvala NJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Riberdy JM; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Abay T; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Stickels RR; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Verboon JM; Department of Pathology, Stanford University, Stanford, CA, USA., Liu V; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Genetics, Stanford University, Stanford, CA, USA., Buquicchio FA; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Wang F; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Southard J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Song R; Allogene Therapeutics, South San Francisco, CA, USA., Li W; Allogene Therapeutics, South San Francisco, CA, USA., Shrestha A; Allogene Therapeutics, South San Francisco, CA, USA., Parida L; IBM Research, New York, NY, USA., Getz G; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Maus MV; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Li S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Moore A; Allogene Therapeutics, South San Francisco, CA, USA., Roberts ZJ; Allogene Therapeutics, South San Francisco, CA, USA., Ludwig LS; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany., Talleur AC; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany., Thomas PG; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA., Dehghani H; Allogene Therapeutics, South San Francisco, CA, USA., Pertel T; Allogene Therapeutics, South San Francisco, CA, USA., Kundaje A; Department of Genetics, Stanford University, Stanford, CA, USA.; Department of Computer Science, Stanford University, Stanford, CA, USA., Gottschalk S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Roth TL; Department of Pathology, Stanford University, Stanford, CA, USA., Kersten MJ; Department of Hematology, University of Amsterdam, Amsterdam, the Netherlands., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Majzner RG; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Division of Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA., Satpathy AT; Department of Pathology, Stanford University, Stanford, CA, USA. satpathy@stanford.edu.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. satpathy@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. satpathy@stanford.edu.
Publikováno v:
Nature [Nature] 2023 Nov; Vol. 623 (7987), pp. 608-615. Date of Electronic Publication: 2023 Nov 08.
Autor:
Spanjaart AM; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands., Pennings ERA; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., van Dorp S; Department of Hematology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., van Doesum JA; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., de Boer JW; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Niezink AGH; Department of Radiation Oncology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Kos M; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam UMC Location University of Amsterdam, 1081 HV Amsterdam, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Sijs-Szabo A; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands., Nijhof IS; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; Department of Internal Medicine-Hematology, St Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Kuipers MT; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Chamuleau MED; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., Serroukh YIM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands., Minnema MC; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., van Meerten T; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Aug 30; Vol. 15 (17). Date of Electronic Publication: 2023 Aug 30.
Autor:
Vinke PC; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands p.c.vinke@umcg.nl susipuig@gmail.com., Combalia M; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.; Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., de Bock GH; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Leyrat C; Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Spanjaart AM; Hematology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE, Amsterdam, The Netherlands., Dalle S; Dermatology, Cancer Research Center of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; University Claude Bernard Lyon 1, Villeurbanne, France.; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France., Gomes da Silva M; Hematology, Portuguese Institute of Oncology, Lisboa, Portugal., Fouda Essongue A; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France., Rabier A; ImmuCare, Cancer Institute of the Hospices Civils de Lyon, Lyon, France., Pannard M; INSERM Unit U1296 Radiation: Defence, Health, Environment, Lumière University Lyon 2 Psychology Institute, Bron, France., Jalali MS; MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts, USA., Elgammal A; Scientific Academy for Service Technology e.V. (ServTech), Potsdam, Germany.; Egypt University of Informatics, Cairo, Egypt., Papazoglou M; Scientific Academy for Service Technology e.V. (ServTech), Potsdam, Germany.; School of Computer Science and Engineering, University of New South Wales, Sydney, New South Wales, Australia.; School of Computing, Macquarie University, Sydney, New South Wales, Australia., Hacid MS; LIRIS, CNRS UMR 5205, Universite Claude Bernard Lyon 1, Villeurbanne, France., Rioufol C; Clinical Oncology Pharmacy Department, Hospital Lyon-South, Cancer Institute of the Hospices Civils de Lyon, Pierre-Benite, France., Kersten MJ; Hematology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE, Amsterdam, The Netherlands., van Oijen MG; Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands., Suazo-Zepeda E; Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Malhotra A; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Coquery E; LIRIS, CNRS UMR 5205, Universite Claude Bernard Lyon 1, Villeurbanne, France., Anota A; Direction of Clinical Research and Innovation & Human and Social Sciences, Centre Léon Bérard, Lyon, France.; French National platform Quality of Life and Cancer, Lyon, France., Preau M; INSERM Unit U1296 Radiation: Defence, Health, Environment, Lumière University Lyon 2 Psychology Institute, Bron, France., Fauvernier M; University Claude Bernard Lyon 1, Villeurbanne, France.; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, Villeurbanne, France., Coz E; University Claude Bernard Lyon 1, Villeurbanne, France.; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, Villeurbanne, France., Puig S; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain p.c.vinke@umcg.nl susipuig@gmail.com.; Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain., Maucort-Boulch D; University Claude Bernard Lyon 1, Villeurbanne, France.; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, Villeurbanne, France.
Publikováno v:
BMJ open [BMJ Open] 2023 Apr 27; Vol. 13 (4), pp. e069090. Date of Electronic Publication: 2023 Apr 27.
Autor:
Spanjaart AM; Amsterdam UMC Location University of Amsterdam, Hematology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; LYMMCARE, Amsterdam, the Netherlands., Pennings ERA; Amsterdam UMC Location University of Amsterdam, Hematology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; LYMMCARE, Amsterdam, the Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands., Kos M; Amsterdam University Medical Centers, University of Amsterdam, Department of Oncology, Amsterdam, the Netherlands., Mutsaers PGNJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, the Netherlands., Lugtenburg PJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, the Netherlands., van Meerten T; University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands., van Doesum JA; University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands., Minnema MC; University Medical Center Utrecht, Department of Hematology, Utrecht, the Netherlands., Jak M; University Medical Center Utrecht, Department of Hematology, Utrecht, the Netherlands., van Dorp S; Radboud University Medical Center, Department of Hematology, Nijmegen, the Netherlands., Vermaat JSP; Leiden University Medical Center, Department of Hematology, Leiden, the Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., van Oijen MGH; Amsterdam University Medical Centers, University of Amsterdam, Department of Oncology, Amsterdam, the Netherlands., Kuipers MT; Amsterdam UMC Location University of Amsterdam, Hematology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; LYMMCARE, Amsterdam, the Netherlands., Nijhof IS; Amsterdam UMC Location University of Amsterdam, Hematology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; LYMMCARE, Amsterdam, the Netherlands.; St Antonius Ziekenhuis Nieuwegein, Hematology, Nieuwegein, the Netherlands., Kersten MJ; Amsterdam UMC Location University of Amsterdam, Hematology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; LYMMCARE, Amsterdam, the Netherlands.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2023 Mar; Vol. 19 (3), pp. e407-e416. Date of Electronic Publication: 2022 Dec 12.